Expert Comparison: Which Treatment Suits Your Goals?
1.7mg Wegovy vs Mounjaro: Complete UK Buying Guide
When comparing 1.7mg Wegovy vs Mounjaro for online purchase in the UK, understanding their distinct mechanisms is crucial for informed decision-making. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, reducing appetite and promoting satiety after smaller meals. Mounjaro contains tirzepatide, which activates both GLP-1 and GIP receptors, offering a dual-pathway approach to weight management.
At this 1.7mg stage, you're approaching maintenance dosing where treatment choice becomes particularly important for long-term success. Both medications require clinical assessment and prescription approval through our regulated UK pharmacy process. EverydayMeds provides both options with identical standards of care, genuine manufacturer supply, and expert prescriber guidance to help you make the right choice for your individual circumstances.
1.7mg Wegovy vs Mounjaro Pricing and Value Comparison
Our 1.7mg Wegovy costs £139.99 for a single pen after applying discount code FIRST40 for new customers, or DOSE25 for returning patients at checkout. For those planning ahead, our Elevate Duo bundle (1.7mg + 2.4mg) provides your transition to maintenance dosing for £369.99. This represents exceptional value for genuine Novo Nordisk Wegovy pens sourced directly from the manufacturer.
Mounjaro pricing follows a different structure due to its distinct manufacturing and dosing protocol. Both treatments include our comprehensive service: 3-minute clinical assessment, expert prescriber review within 3 working days (or 24 hours with express service), and next-day cold-chain delivery. The total cost of ownership depends on your individual response, maintenance dosing requirements, and long-term treatment planning—factors our prescribers discuss during assessment.
Clinical Evidence: 1.7mg Wegovy vs Mounjaro Trial Data
Wegovy's efficacy is established through the STEP trial programme, where patients taking Wegovy alongside diet and exercise achieved average weight loss of approximately 15% at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 5 trial demonstrated sustained weight loss of approximately 15.2% at 2 years, while the recent SELECT trial showed a 20% reduction in major cardiovascular events.
Mounjaro's evidence comes from the SURMOUNT trials, showing different endpoints and patient populations, making direct comparison inappropriate. Both treatments demonstrated efficacy in their respective clinical programmes when used alongside reduced-calorie diet and increased physical activity. Your prescriber will consider this evidence alongside your medical history, treatment goals, and individual risk factors when recommending between 1.7mg Wegovy vs Mounjaro options.
How Wegovy Works: GLP-1 Mechanism for Weight Management
Wegovy works by activating GLP-1 receptors in your brain and digestive system, mimicking a natural hormone that signals fullness and satiety. This mechanism reduces appetite between meals, helps you feel satisfied with smaller portions, and may reduce food cravings by influencing brain appetite centres. The 1.7mg dose represents your penultimate step before reaching the 2.4mg maintenance dose, where maximum therapeutic benefit typically occurs. Unlike Mounjaro's dual-receptor approach, Wegovy's single-pathway mechanism has extensive long-term safety data and established clinical protocols. This prescription-only medicine must be used alongside lifestyle modifications including reduced-calorie diet and increased physical activity for optimal results.
UK Online Ordering Process for 1.7mg Wegovy vs Mounjaro
Our streamlined ordering process applies to both 1.7mg Wegovy and Mounjaro purchases through our GPhC-registered pharmacy. Complete our 3-minute clinical assessment covering your medical history, current medications, and weight management goals. Our expert prescribers review every application within 3 working days (or 24 hours with express service), ensuring appropriate prescribing for your circumstances. Once approved, we dispatch your medication via next-day delivery using temperature-controlled cold-chain logistics to maintain product integrity. All consultations include ongoing prescriber support, dose escalation guidance, and access to our clinical team for questions about your treatment. This comprehensive service ensures safe, legal access to prescription-only medicines through our regulated UK pharmacy.
Storage and Practical Considerations: 1.7mg Wegovy vs Mounjaro
Wegovy offers a significant practical advantage with 6 weeks room temperature storage (below 30°C) once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. Store unused Wegovy pens in the fridge at 2-8°C until first use, then they can travel with you for up to 6 weeks. The FlexTouch pen design provides reliable dose delivery with an audible click confirmation when injection completes. Dose escalation from 1.7mg follows a strict protocol—you cannot skip the 2.4mg maintenance dose even if tolerating 1.7mg well. Each pen contains 4 doses of 1.7mg semaglutide, administered once weekly on the same day each week, providing one month of treatment per pen.
1.7mg Wegovy vs Mounjaro: Advanced Treatment Planning
At the 1.7mg stage, you're making critical decisions about long-term treatment sustainability and maintenance planning. Wegovy's established dose escalation pathway provides clear progression to 2.4mg maintenance, with extensive real-world data supporting long-term use. The STEP 1 extension study showed patients regained approximately two-thirds of weight lost within one year of stopping treatment, emphasising weight management as a long-term commitment.
Mounjaro offers alternative dosing flexibility with its tirzepatide formulation, potentially suiting patients who require different therapeutic approaches. When comparing 1.7mg Wegovy vs Mounjaro for UK purchase, consider factors like storage convenience, dose escalation protocols, long-term cost planning, and individual response patterns. Our prescribers specialise in matching patients with optimal treatments based on comprehensive clinical assessment rather than one-size-fits-all approaches.
Secure Your 1.7mg Wegovy vs Mounjaro Treatment Today
Both Wegovy and Mounjaro are available from EverydayMeds—your prescriber can help determine which treatment aligns with your clinical profile and weight management objectives. Use discount code FIRST40 for new customers or DOSE25 for returning patients to access our best pricing at checkout. Our clinical assessment takes just 3 minutes, with expert prescriber review ensuring appropriate, safe prescribing for your circumstances. Start your assessment today at our regulated UK pharmacy (GPhC #9012878) and take the next step in your weight management journey with confidence. Whether you choose 1.7mg Wegovy or Mounjaro, our comprehensive support ensures you receive genuine, manufacturer-sourced medication with professional clinical oversight throughout your treatment.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
